
Greystone Associates Assesses Key Enablers and Success Factors for Pen Injectors and Auto-Injectors
(Amherst, NH) – Aging population demographics and managed care initiatives are major forces driving the growth of home healthcare, a trend that includes the self-administration of drug therapies for chronic conditions such as diabetes, arthritis, and hormone replacement therapy. This trend is creating an increased interest in routes of administration that are patient-friendly and cost-effective.
Driven by application specific design features and consumer-oriented focus, pen injectors continue to benefit from this trend. User-friendly designs and the availability of an increasing number of drugs in pre-filled disposable cartridges and syringes are fueling the growth of injector pens at the expense of other drug delivery methods such as traditional syringes. Advances in synthetic materials and concurrent development partnerships between pen designers and drug developers are also important factors in the growth of this segment.
Pen injectors are already a leading drug delivery method in Europe where more than half of all diabetics use them to administer insulin injections. In other major therapeutic areas such as the administration of immune modulators for the treatment of autoimmune diseases and Hepatitis C, they have quickly gained market share and become a dominant factor in self-care for millions of patients.
These findings are contained in a new and comprehensive report: Pen Injectors: Devices, Drugs and Disease Therapeutics. The survey concludes that pen injectors will continue to expand as device designers create pen devices that address the specific needs of end users.
More information is available at
http://www.greystoneassociates.org/Pen_Injectors.htm
About Greystone
Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.
Contact:
Mark Smith
Voice: 603-595-4340
Fax: 603-804-0466
www.greystoneassociates.org
Source: Greystone Associates
Comment and add to the story without registration, but keep the comments meaningful please. Links are not accepted.
